We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$342M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$83.1M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$43.8M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$40.2M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$26.6M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 8.04%
3 Healthcare 7.14%
4 Communication Services 6.4%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AWH
3651
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$22K ﹤0.01%
458
+81
+21% +$5.01K
MTEM
3652
DELISTED
Molecular Templates, Inc.
MTEM
$22K ﹤0.01%
221
-527
-70% -$54.3K
STSA
3653
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$22K ﹤0.01%
4,707
+2,206
+88% +$11.7K
ATHX
3654
DELISTED
Athersys, Inc. Common Stock
ATHX
$22K ﹤0.01%
643
-1,096
-63% -$41.6K
ACBI
3655
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$22K ﹤0.01%
816
-1,003
-55% -$24.5K
LORL
3656
DELISTED
Loral Space and Communications, Inc.
LORL
$22K ﹤0.01%
492
-2,501
-84% -$97K
ATLC icon
3657
Atlanticus Holdings
ATLC
$1.48B
$21K ﹤0.01%
403
-112
-22% -$5.47K
FRMM
3658
Forum Markets
FRMM
$81.8M
$21K ﹤0.01%
+1
New +$27.3K
BATRK icon
3659
Atlanta Braves Holdings Series B
BATRK
$3.41B
$21K ﹤0.01%
791
-718
-48% -$18.9K
CHT icon
3660
Chunghwa Telecom
CHT
$32.8B
$21K ﹤0.01%
529
-1,016
-66% -$41.5K
DRMA icon
3661
Dermata Therapeutics
DRMA
$6.31M
$21K ﹤0.01%
+2
New +$23.7K
ERAS icon
3662
Erasca
ERAS
$6.25B
$21K ﹤0.01%
+981
New +$20.2K
ERII icon
3663
Energy Recovery
ERII
$397M
$21K ﹤0.01%
1,106
-488
-31% -$9.91K
GSAT icon
3664
Globalstar
GSAT
$10.8B
$21K ﹤0.01%
862
-262
-23% -$6.43K
HTLD icon
3665
Heartland Express
HTLD
$950M
$21K ﹤0.01%
1,294
-355
-22% -$5.92K
KRON
3666
DELISTED
Kronos Bio
KRON
$21K ﹤0.01%
968
-504
-34% -$10.8K
MBWM icon
3667
Mercantile Bank Corp
MBWM
$1.06B
$21K ﹤0.01%
682
-4,757
-87% -$147K
DFTX
3668
Definium Therapeutics
DFTX
$5.9B
$21K ﹤0.01%
612
-4
-0.6% -$173
MORN icon
3669
Morningstar
MORN
$7.41B
$21K ﹤0.01%
83
-63
-43% -$16.6K
NMFC icon
3670
New Mountain Finance
NMFC
$728M
$21K ﹤0.01%
1,598
-1,889
-54% -$25.3K
NNOX icon
3671
Nano X Imaging
NNOX
$73.2M
$21K ﹤0.01%
952
-7,660
-89% -$201K
ORN icon
3672
Orion Group Holdings
ORN
$402M
$21K ﹤0.01%
3,882
+2,891
+292% +$15.8K
PRAX icon
3673
Praxis Precision Medicines
PRAX
$10.8B
$21K ﹤0.01%
76
-210
-73% -$57K
RDI icon
3674
Reading International Class A
RDI
$32.7M
$21K ﹤0.01%
+4,156
New +$22K
ROCK icon
3675
Gibraltar Industries
ROCK
$1.46B
$21K ﹤0.01%
300
-1,218
-80% -$87.6K
145 146
147
148 149

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.